Atherosclerotic Renal Artery Stenosis: Overtreated but Underrated?

摘要: Despite evidence of only moderate clinical benefit, application renal endovascular stent procedures has increased at least four-fold in the past decade. Medicare is reviewing national coverage regarding reimbursement, questioning whether outcome data warrant many these procedures. Several prospective, randomized trials are now progress to compare outcomes with optimized medical therapy and without stenting. Current imaging methods establish primarily presence severity vascular occlusive disease. Optimal treatment for individual patients remains flux reviewed here. Most important, nephrologists await development tools predict reliably when parenchymal injury beyond recovery and/or revascularization can produce meaningful salvage kidney function.